# Vitalant – FDA Inspection, Aug 29, 2025

Source: https://www.keypedia.com/records/fda_inspections/vitalant/ae29ad84-6e79-4024-92d2-f7c31489fdac
Source feed: FDA_Inspections

> FDA inspection 1281750 of Vitalant, August 29, 2025. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1281750
- Company Name: Vitalant
- Inspection Date: 2025-08-29
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1167691 - 2022-04-12](https://www.keypedia.com/records/fda_inspections/vitalant/74a42180-2e05-4740-ad33-77c4778528dd)
- FDA Inspection 1037711 - 2017-12-07
- FDA Inspection 979707 - 2016-07-21
- FDA Inspection 871353 - 2014-02-28
- FDA Inspection 784588 - 2012-05-18

## Related Officers

- [Michele Gottshall](https://www.keypedia.com/people/michele-gottshall/f12dcaf7-8958-4591-88bb-f9746796b934)

Company: https://www.keypedia.com/companies/vitalant/f05cb944-4412-45b4-9314-3b7733e6379b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d